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ABSTRACT
Objective: The concept of the synergistic effect of poly-herbalism was as old as medicine history. Present novel polyherbal formulation (PHF) 
composed of five different herbs. The present investigation aimed to evaluate the synergistic therapeutic hypoglycemic potential of PHF against 
streptozotocin (STZ) (60 mg/kg b.w, ip)-induced diabetic rats.
Methods: For this therapeutic study, the dose was framed orally once a day to the test objects after STZ dosing at 500 mg/kg/5 ml dosage levels for 
21 days. The transformation of body weight and blood glucose level was examined, and the histopathological changes of beta cells of the pancreas, 
cellular architectures of liver and kidney were also perceived after scarification of the objects.
Results: The outcomes were compared to that of glibenclamide (5 mg/kg) treated group. Declines of body weight and blood glucose levels were 
perceived in STZ-induced diabetic animals very significantly (p<0.01 or p<0.05). However, these diabetic changes were significantly (p<0.01 or p<0.05) 
decreased in PHF-dosing groups revealed more encouraging effects compared to that of glibenclamide. In the other hand, various liver function and 
enzymes test (creatinine, urea, total bilirubin, total albumin, alkaline phosphatase, gamma-glutamyl transferase, aspartate transaminases, and alanine 
transaminases) and lipid profile (total cholesterol, triglycerides, high-density lipoprotein cholesterol, total protein, low-density lipoprotein [LDL], and 
very LDL) studies strongly indicate the potential action of this novel formulation.
Conclusions: It is deliberated that PHF has the favorable effect to normalize the blood glucose levels, and also rejuvenation and reproduction of beta 
cells lead a better futuristic ant diabetic therapy for diabetic management.
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INTRODUCTION
High blood sugar generally termed as hyperglycemia. It is a condition 
of abnormally high blood glucose level in the blood characterized by 
the sign of diabetes and pre-diabetes conditions. Diabetes is a chronic 
metabolic disorder characterized by hyperglycemia due to inadequate 
insulin-making or non-appropriate response by cell or both. It obstructs 
directly in the metabolism of macronutrients. Patients with high blood 
sugar will characteristically experience polyuria, polydipsia, and 
polyphagia. Categories of diabetes are referred to as type 1 and type 2 
which is non-insulin-dependent diabetes, or juvenile onset and adult-
onset diabetes. Hyperglycemia indications to various diseases such as 
cardiovascular, hepatic, vision, dental, nerve, and foot ulcer. Around 
6% world population currently suffering from this disorder and it also 
likely to be changing its dynamics frequently as especially in developing 
nations [1]. There is a rough estimate say, near about 36 million world 
populations are undiagnosed of this rapidly growing miserable problem. 
As per the IDF report, China, India, and the USA will go to host the 
world 80% total diabetic population on 2030 [2]. Treatment of various 
metabolic disorders by poly-herbalism has been recognized in ancient 
documents like “Sarangdhar Samhita” dated in 1300 A.D. The presence 
of various phytoconstituents leads to the significant therapeutic 
efficacy of herbal medicines further potentiated when formulated 
together with compatible herbals in formulations. It is evident that 
a better therapeutic effect can be reached with multi-constituent 
formulations. Combination of herbals may act on multiple targets at the 
same time to provide a thorough relief [3]. Multi-herbal combination 
therapy can achieve greater hypoglycemia than monotherapy and can 
also enhance the safety and tolerability of pharmacotherapy. The plant 
parts, namely, Cassia auriculata L. [4,5], Mangifera indica [6,7], Ficus 
banghalensis [8,9], Cinnamomum tamala [10,11], and Trichosanthes 
diocia [12,13], are abundantly found throughout the Indian 
subcontinent and scientifically proven for their moderate hypoglycemic 
potentials and other pharmacological actions. However, the synergistic 
potential of those herbs on hyperglycemia in the form of the poly-
herbal formulation (PHF) has not been investigated till date. Hence, 
the present investigation aimed to evaluate the synergistic therapeutic 
hypoglycemic potential of PHF against experimentally induced diabetic 
rat models in vivo.
METHODS
Chemicals used
Various experimental chemicals were procured from multiple sources, 
vis. Streptozotocin (STZ), analytical grade laboratory reagents and 
chemicals from HiMedia Laboratories, Mumbai, India, SD Fine Chem, 
Bengaluru, respectively, and Commercial reagent kits obtained from 
Karnataka fine Chem Ltd., Bengaluru.
Collection of the plant
Parts of the plants, namely C. auriculata, C. tamala, Ficus benghalensis, 
M. indica, and Trichosanthes dioica were collected from in an around 
Kerala state and authenticated. Each plant specimen voucher was 
deposited in the Department of Pharmacognosy, Rajiv Gandhi Institute 
of Pharmacy, Trikaripur, India, for future reference. The respective 
voucher numbers were given for each herb as shown in Table 1.
Extraction of plant material and extract preparation
All the procured parts of plants (Table 1) were subjected to shade 
drying and after powdered and passed through 20# sieve. Those 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i3.29969
Research Article
219
Asian J Pharm Clin Res, Vol 12, Issue 3, 2019, 218-223
 Majumder and Paridhavi 
prepared plant powder materials were individually macerated with 
distilled water (1:10), and all the aqueous plant extracts were imperiled 
to lyophilization. Lyophilized extracts were store at airtight container 
and store in a dark, cool place for further use.
Experimental animals
The animal experimentation was carried out using either sex of adult 
Wistar albino rats (180±10 g). Before the experiment, all the animals 
were placed in-house in polyacrylic cages with dark and light 24 h cycle at 
ambient room temperature with free access of water and rodent pellets 
diet. The animal experimentation protocol was approved by IAEC of 
Rajiv Gandhi Institute of Pharmacy and experimentation was carried out 
as per the CPCSEA guidelines. Preliminary screening for phytochemical 
1 g each of lyophilized plant extracts was dissolved in 100 ml of distilled 
water and subjected to qualitative analysis of phytochemicals such as 
alkaloids, tannins, glycosides, flavonoids, phenolic compounds, and 
saponins as per standard chemical methods [2].
Development of PHF
About 1 g each of lyophilized plant extracts were dissolved in 100 ml of 
distilled water and subjected to qualitative analysis of phytochemicals 
such as alkaloids, tannins, glycosides, flavonoids, phenolic compounds, 
and saponins as per standard chemical methods [2].
Total phenolic content (TPC) determination
Sample stock preparation was done with 50% methanol in 100 ml 
volumetric flask with triplicate maceration of 1 g PHF in methanol. 
1 ml aliquot diluted 10 times with distilled water and later added with 
1.5 ml Folin–Ciocalteu’s reagent. The solution mixture was incubated 
for 5 min at room temperature. After incubation solution mixture was 
further added with 4 ml of 20% Na2CO3 (w/w) and make up the volume 
up to 25 ml with distilled water. The reaction mixture was agitated and 
keeps for 30 min at room temperature. The absorbance was measured at 
765 nm in UV spectrophotometer against the blank. Similarly, standard 
gallic acid stock sample also prepared with methanol (100 µg/ml), and 
various dilutions concentrations were prepared such as 6.25, 12.5, 25, 
and 50 µg/ml and standard gallic acid curve also been plotted against the 
absorbance at 765 nm by UV spectrophotometer against the blank [14].
% TPC (w/w) = GAE×V×D×10–6×100/W,
GAE - Gallic acid equivalent (µg/ml), V - total volume of sample (ml), 
D - Dilution factor, W - Sample weight (g).
Total flavonoid content (TFC) determination
Standard rutin stock solution is prepared (100 µg/ml) using 80% 
methanol and various dilute concentrations such as 10, 20, 40, 80, and 
100 µg/ml been prepared. Each 0.5 ml standard rutin dilution is added 
with 1.5 ml 95% methanol, 0.1 ml of 10% aluminum chloride, 0.1 ml 
1M potassium acetate, and 2.8 ml of distilled water and incubated for 
30 min at room temperature. Absorbance measured at 415 nm using 
UV spectrophotometer against the blank. Similarly, 1 g of PHF dissolved 
separately in 25 ml of 80% methanol for determination of flavonoids 
content as described above [14].
%total flavonoids content (w/w) = RE×V×D×10–6×100/W
RE - rutin equivalent (µg/ml), V - total volume of sample (ml), D - dilution 
factor, W - sample weight (g).
Study for acute toxicity
The study was performed as per the OECD guideline-425. Experimental 
Wister rats were fasted overnight before the study. Fasted animals were 
divided into four groups of six animals each. Individual groups were 
administered orally with PHF dose from 250, 500, and 1000 and 2000, 
4000, and 5000 mg/kg b.w, respectively. All the groups of animals were 
initially observed for 1 h and periodically for next 24 h up to 14 days 
for any gross behavioral changes such as drowsiness, restlessness, 
writhing, convulsions, symptoms of toxicity, and mortality.
Oral glucose tolerance test (OGTT) on normal and diabetic animals
Experimental animals were randomly selected and grouped into 
three of six each. The Groups I and II were treated with the vehicle 
carboxymethylcellulose solution (0.5% w/v in normal saline) and PHF 
(500 mg/kg b.w), respectively. Whereas Group III was treated with 
standard glibenclamide (1 mg/kg b.w), Groups II and III were administered 
with PHF and glibenclamide and after 30 min all the experimental animals 
including Group I was fed orally with 2 g/kg of glucose solution. After a 
particular time interval, namely 0, 30, 60, 90, and 120 min, blood was 
withdrawn from the tail vein. The estimation of blood glucose level was 
measured by Accu-Chek, Roche Diabetes Care India [15].
Hypoglycemic activity in STZ-induced diabetic rats
Experimental diabetes was induced by 0.5 ml/kg b.w IP injection of 
freshly prepared STZ (50 mg/kg b.w. in 0.1 M citrate buffer at pH 4.5) 
in overnight fasted animals [16]. After 24 h, the STZ treated animals 
were given with glucose solution (5% w/v) at the dose of 2 ml/kg bw to 
prevent the mortality due to hypoglycemic shock. The induced rats with 
fasting blood glucose >300 mg/dl were considered as diabetics and 
taken for hypoglycemic activity. Experimental animals (male Wistar rats) 
were divided into three groups with six animals each. Groups II–IV were 
designated as diabetic control. Glibenclamide (5 mg/kg bw) treated and 
PHF (500 mg/kg, bw) treated groups. Another six animals were taken 
as normal control without STZ as Group I. Except the Groups I and II; 
all other groups were treated with standard glibenclamide and PHF 
(suspended in 1% w/v carboxymethylcellulose) through oral gavage for 
21 consecutive days. During this time period blood, samples were been 
taken through the retro-orbital route of the animal in a specific time 
interval such as 0 day, 7th day, 14th day, and 21st day for estimation of 
blood glucose level. The estimations were done by Chem Biochemistry 
Analyzer (AN Biotech, India). Body weight of experimental animals also 
measured in this specified time intervals.
Blood collection and harvestmen of organs
Blood collection and harvesting of organs were taken place after a 
21st day of experimentation. The animals were sacrificed by ether 
anaesthetization, and an aliquot of blood (5 ml) was collected from a 
jugular vein in plain and ethylenediaminetetraacetic acid tubes tube 
and centrifuged at 1282 g × 5min. After centrifugation, the serum 
was separated with Pasteur Pipette in plain tubes and subjected for 
biochemical estimations [17]. Meanwhile, the rats were dissected, 
and the organs were isolated such as whole liver, pancreas, and two 
kidneys. After isolation, the specimens are freed from extracellular 
fats and deposited in formalin solution for further histopathological 
investigations.
Lipid profile and total protein estimations
The entire estimations of lipid profiles such as total cholesterol, 
triglycerides, high-density lipoprotein (HDL)-cholesterol, and low-
Table 1: Authentication of herbs present in the PHF
Herbs Family Code Part used Voucher No
Cassia auriculata L. Caesalpiniaceae CA Flower PG/CA/F-001
Cinnamomum tamala Lauraceae CT Leaves PG/CT/L-003
Ficus benghalensis L. Moraceae RB Root bark PG/FB/B-003
Mangifera indica L. Anacardiaceae MI Leaves PG/MI/L-002
Trichosanthes dioica Cucurbitaceae TD Arial parts PG/TD/AP-001
PHF: Polyherbal formulation
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density lipoprotein (LDL)-cholesterol along with total protein were 
screened with the standard procedure using Chem Biochemistry 
Analyzer (AN Biotech, India) [22].
Liver and kidney function tests
Estimation of serum creatinine [19], urea [20], uric acid [21], total 
bilirubin [22], albumin [23], and alkaline phosphatase (ALP) [24], 
gamma-glutamyltransferase (GGT) [25], aspartate transaminases 
(AST), and alanine transaminases (ALT) [26] was carried out using 
standard procedure.
Histopathological analysis
The preserved organs were further taken to the microscopic slide 
with egg albumin and allowed to dry. After dehydration, the tissues 
were subjected to xylene solution for 15–20 min for further cleaning. 
Clean tissues were put in paraffin infiltration in the automatic tissue 
processing unit, and tissue blocks were prepared. The thin sections 
(5 µm) of tissue were obtained using microtome. The sections were 
further taken to the microscopic slide with egg albumin and allowed to 
dry. Finally, staining of the sections done with an acidic and basic dye, 
namely Eosin and hematoxylin, respectively [27,28].
Statistical analysis
The experimental data produced as mean ± SEM. All statistical 
significance were found in groups were established by one-way analysis 
of variance (ANOVA) followed by Dunnett’s t-test post hoc test. p<0.5 
was considered significant [29].
RESULTS
Preliminary screening of phytochemicals
Preliminary phytochemical screening of PHF indicates the presence of 
phytochemicals such as alkaloids, glycosides, tannins, flavonoids, and 
phenolics in the mixture.
TPC and TFC of PHF
In this PHF, TPC and TFC were found to be 81.01±15 GE/g and 10.16±11 
RE/g (Table 2), respectively.
Study of acute toxicity
PHF was found to be non-toxic at the optimum dose of 5000 mg/kg bw. 
There was no evidence of behavioral change in the animals observed 
even no mortality as well. Any other symptoms such as breathing, 
sensory nervous system, gastrointestinal effects, or toxicity also were 
found absent in all experimental animals during the observational 
period indicating the high margin of safety of PHF.
OGTT on normal and experimental rats
There was a significant (p<0.05) reduction of blood plasma glucose 
level in PHF-treated group and glibenclamide (0.25 mg/kg)-treated 
group compared to normal control (Table 3) whereas no significant 
change observed in normal control animals during the period of study.
Hypoglycemic activity of PHF in diabetic-induced rats
PHF-treated group has been shown a significant reduction about 
91.83±2.96 mg/dl of blood sugar compared to the diabetic control 
group, whereas 123.83±2.11 mg/dl found in glibenclamide-treated 
group. These results indicate the normalization of blood sugar level 
with PHF in diabetic rats (Tables 4 and 5) as compared to normal 
control group (90.83±1.77 mg/dl) of animals.
Total protein and lipid profile test
The automatic analyzer has been employed for the screening of 
total cholesterol, triglycerides, HDL-cholesterol, total protein, LDL, 
and VLDL, respectively, in blood serum of experimental animals 
(Table 6) [18].
Liver and kidney function tests
The concentrations of creatinine [19], urea [20], total bilirubin [22], 
albumin [23] as well as the activities of ALP [24], GGT [25] and AST, ALT, 
and BUN [26] were determined in the serum (Table 7).
Histopathologic analysis
Kidney
The histological sections showed intact cellular architecture and 
normal cellularity in the glomerulus. The normal group showed the 
intact tubules (Fig. 1a) and blood vessels. Interstitium showed to 
be unremarkable. Most of the tubules in the diabetic group showed 
degenerative changes (Fig. 1b) with dispersed interstitial inflammatory 
mononuclear infiltration. The glibenclamide treated groups showed 
moderate degenerative changes in few tubules (Fig. 1c), whereas 
minimal degenerative tubules changes (Fig. 1d) found in the PHF 
treated group.
Table 2: TPC and TFC of PHF
TPCa 81.01±1.50
TFCb 10.16±1.13
Values are means±SEM of three replicate studies. aGE/g: Mg gallic acid 
equivalent, bQE/g: Mg rutin equivalent. TPC: Total phenolic content, TFC: Total 
flavonoid content, PHF: Poly-herbal formulation
Table 3: OGTT
Groups Blood glucose levels(mg/dl)
Treatments 0min 30min 60min 90min 120min
Group1 Normal control 92.28±2.57 143.33±2.08 134.33±2.99 120.19±2.99 95.66±2.06
Group2 PHF(500 mg/kg) 92.76±3.62 127.34±1.96 116.45±4.25 103.22±3.23* 96.51±3.59
Group4 Glibenclamide(0.25mg/kg) 91.58±2.96 119.21±2.11** 102.65±3.02** 96.35±2.96** 90.54±3.52
Values are mean±SEM, n=6, *p<0.05, **p<0.01 compared to normal control group. One-way ANOVA followed by Dunnett’s multiple comparison test, OGTT: Oral glucose 
tolerance test, PHF: Poly-herbal formulation




0Day 7th Day 14th Day 21st Day
Normal control 90.83±3.93 95.33±3.09 92.66±4.06 90.83±1.77
Diabetic control 370.00±3.00 390.50±3.50 403.16±4.94 415.33±3.54
Diabetic+glibenclamide 371.66±2.68 277.66±4.42** 190.66±2.28* 123.83±2.11*
Diabetic+PHF 364.16±4.29* 272.00±4.19** 141.83±3.80** 91.83±2.96**
All values are expressed as mean±S.E.M(n=6). *p<0.05, **p<0.01 as compared to diabetic control. One-way ANOVA followed by Dunnett’s multiple comparison test, 
PHF: Poly-herbal formulation
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Pancreas
The histological study reveals the septal separation of pancreatic 
lobules. Few of the lobules showed small areas of light-staining islets 
of Langerhans. Around 65% of small beta cells in central islet cells 
were been found in normal control groups (Fig. 1e [long-arrow]), and 
30% large alpha-cells seen in the periphery (Fig. 1e [short-arrow]). 
In diabetic control section, most of the beta cells show degenerative 
changes with 40% beta-cell in center of islet cells (Fig. 1f [long-arrow]), 
while the periphery comprises 55% large alpha-cells (Fig. 1f [short-
arrow]). The glibenclamide-treated animal pancreatic cells showed 
some degenerative changes of the beta cells. The center of islet cells 
consists of 50% small beta-cells (Fig. 1g [long-arrow]), while the 
periphery comprises 45% large alpha-cells (Fig. 1g [short-arrow]). 
In PHF-treated section studied shows the center of islet cells consist 
of 65% small beta-cells (Fig. 1h [long-arrow]), while the periphery 
comprises 30% large alpha-cells (Fig. 1h, [short arrow]). Intervening 
these cells is seen vascular spaces in all the sections.
Liver
All the sections showed liver parenchyma with intact architecture, 
the periportal, perivenular, and mid zonal hepatocytes appear 
unremarkable. In Normal control, the central veins and  Sinusoids 
appear unremarkable  (Fig. 1i). Sinusoids appear unremarkable. 
Whereas in diabetic control Section showed the periportal region 
had dense mononuclear inflammatory infiltration (Fig. 1j). Standard 
glibenclamide-treated group section reviled the unchanged central 
veins (Fig. 1k) and sinusoids. In the case of PHF-treated groups section 
studied shows that the periportal region shows moderate mononuclear 
inflammatory infiltration (Fig. 1l). The central veins and sinusoids 
appear unremarkable as like all the sections.
DISCUSSION
The concept of poly-pharmacy has been practicing since from ancient 
time. The proven examples are listed in various Ayurveda literature. This 
trend also recognized by the WHO in some clinical aliment like diabetes 
which is a metabolic disorder associated with polydipsia and polyphagia.
Lyophilized aqueous plant extracts were been used to formulate the 
PHF to minimize the residual solvent toxicity. All those used herbs 
were also proven for their antioxidant properties. The PHF consisting 
of various important phytoconstituents such as alkaloids, tannins, 
glycosides, flavonoids, and phenolic compounds, where later two are 
natural antioxidants, reported to significantly increase superoxide 
dismutase (SOD), glutathione and catalase activities eventually 
promoters the expression of SOD, catalase, and glutathione [27]. The 
endothelial dysfunctions due to hyperlipidemia, hyperinsulinemia, 
and hyperglycemia are the result of oxidative stress [28], which 
leads to diabetes mellitus. The reduction of antioxidant enzymes, 
inactivation of enzymes and lipid peroxidation cause cell death 
while free radicals get excess produces. The presence of a significant 
amount of phenolic and flavonoids contents makes this formulation 
potent scavenging and antioxidants in biological systems. As per 
existing studies on diabetes mellitus, it has been observed that 
the progression of this disorder leads to boosting the free radicals 
and potentially decrease the cellular antioxidant capacity leads 
to oxidative stress even both insulin dependent and independent 
diabetes mellitus [29]. The tolerability with high dose (5000 mg/
kg b.w) in experimental animals reflects the effect of altered 
carbohydrate metabolism during the post-glucose administration. 
The prolonged hypoglycemic study evident significant decrease in 
blood glucose level may be due to the synergistic effect of all bioactive 
phytochemicals in various bio levels. The results also correlate with 
the study carried by El-Baz1 et al., 2017, on Haematococcus pluvialis 
where the bioactive principles found were the flavonoids [27]. Rats 
orally treated with the PHF at a dose level of 500 mg/kg of b. w were 
found to have significantly reduced activities of these enzymes, 
thus indicating less damage to hepatocytes. Similar action was also 
Table 5: Change of body weight in normal and experimental rats
Groups Body weight(g)
0Day 7th Day 14th Day 21st Day
Normal control 181±2.8 182±3.8 184±2.0 186±3.1
Diabetic control 178±3.7 174±3.2 170±2.9 168±3.4
Diabetic+glibenclamide 190±2.1 190±2.2** 194±3.1** 196±1.6** 
Diabetic+PHF 180±1.9 182±3.1* 185±2.6* 189±3.2*
All values are expressed as mean±S.E.M(n=6). *p<0.05, **p<0.01 as compared 
to diabetic control. One-way ANOVA followed by Dunnett’s multiple comparison 
test. PHF: Poly-herbal formulation
Table 6: Analysis of serum lipid profile and total protein
Biochemical Parameters Normal control Diabetic control Diabetic+Glibenclamide Diabetic+PHF
Cholesterol(mg/dl) 53.57±2.95 63.01±2.46 55.82±4.59 50.25±2.85
Triglyceride(mg/dl) 30.98±2.81 48.79±2.89 32.70±1.90* 29.06±3.66*
HDLc(mg/dl) 17.75±0.35 23.11±0.44 20.25±1.47 19.25±0.14*
Total protein 07.21±0.12 07.27±0.30 07.22±0.26 07.23±0.21
LDL(mg/dl) 07.03±1.85 15.91±1.50 05.91±2.63* 05.17±1.55*
VLDL(mg/dl) 06.19±0.56 09.75±0.58 06.54±0.38* 05.85±0.73*
All values are expressed as mean±S.E.M(n=6). HDLc: High-density lipoprotein-cholesterol, LDL: Low-density lipoprotein, VLDL: Very low-density lipoprotein, *p<0.05, 
**p<0.01 as compared to diabetic control. One-way ANOVA followed by Dunnett’s multiple comparison test
Table 7: Liver and kidney function tests
Biochemical Parameters Normal control Diabetic control Diabetic+glibenclamide Diabetic+PHF
Creatinine(mg/dl) 0.536±0.01 0.606±0.03 0.556±0.01 0.540±0.02*
Urea(mg/dl) 42.61±2.80 59.44±1.79 46.53±3.15* 45.48±6.02*
Total bilirubin(µmol/l) 0.24±0.08 0.228±0.08 0.216±0.084 0.235±0.09
Albumin(g/dl) 3.32±0.13 3.15±0.34 3.22±0.10 2.93±0.13**
ALP(U/L) 261.83±4.23 568.83±4.27 280.86±3.99* 288.45±5.19*
GGT(U/L) 2.01±1.56 8.04±5.85 2.95±2.71* 3.05±2.10
AST(U/L) 155.8±4.14 263.50±3.91 159.93±4.63* 155.11±7.22*
ALT(U/L) 66.05±2.90 131.96±3.86 86.4±4.31 90.06±3.18*
BUN(mg/dl) 17.57±0.35 27.77±0.25 24.23±0.51 25.15±0.34
All values are expressed as mean±S.E.M(n=6). ALP: Alkaline phosphatase, GGT: Gamma-glutamyl transferase, AST: Aspartate transaminases, ALT: Alanine transaminases, 
*p<0.05, **p<0.01 as compared to diabetic control. One-way ANOVA followed by Dunnett’s multiple comparison test
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been reported by Talha et al., 2015, in their study on the  effects of 
the ethanolic extract of Alocasia indica rhizomes [30]. STZ-induced 
diabetic rats are associated with hyperlipidemia and increased levels 
of serum creatinine which all significantly controlled by PHF. The 
lowering of these lipid substances and serum creatinine in the blood 
of treated rats is presumed mainly to be a manifestation of lowering 
of blood glucose level. Low protein degradation found in PHF 
treated animals which leads to high serum protein concentration. 
Due to the reduction in lowering of glucose levels thus sparing the 
body fat and muscle protein which otherwise are utilized in diabetic 
rats probably indicates the elevation of body weight among the rats 
administered with PHF.
CONCLUSION
The common symptoms of diabetes, that includes polyphagia, 
polydipsia, and weight loss, were found to be lessened by the PHF dose 
level of 500mg/kg of b. w in diabetic rats. Along with the significant 
reduction of fasting glucose level and lipid profile of diabetic rats 
were the outcome of this study. The PHF was found significantly 
decreasing the activities of liver enzymes and ALP in diabetic rats. The 
histopathological investigation along with the biochemical evaluations 
strongly suggests the hypoglycemic potential of PHF. The results also 
indicate the effect of PHF on the regeneration of pancreatic β-cells 
leading to blood glucose regulation in the body.
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